Purpose of Review This paper focuses on the sleep disorders in patients with spinal cord injury/disorder (SCI/D), particularly mechanism of sleep-disordered breathing (SDB) and challenges in diagnosis and management. Based on a review of recent literatures and studies, the paper summarizes some main challenges with respect to management of SDB in patients with SCI; what are the responsible mechanisms of disease? What are the barriers in diagnosing and treating SDB using standard treatment such as continuous positive airway pressure (CPAP)? Recent Findings Previous studies have shown that most SCI/ D patients have SDB with heterogeneity in prevalence mainly related to using different definitions or methods of diagnosing SDB, while recent studies using new definition of SDB based on recommended criteria from the American Academy of Sleep Medicine (AASM) and also include the data on effect of SCI/D level on prevalence and describe different types of SDB. Furthermore, recent data describes simplified method of diagnosing SDB by using a combination of home sleep apnea testing and transcutaneous CO 2 monitoring. Finally, emerging data has been pointing at strong relationship between SDB and cardiovascular disease including nocturnal hypertension in patients with SCI/D. Summary The findings indicate that early testing for SDB and associated cardiovascular disease in patients with SCI is recommended and could be beneficial in reducing the high morbidity and mortality in this group of patients with disability. In addition, studies on treatment of other sleep disorders in SCI/ D are not available to inform clinical decision-making. Understanding the pathophysiology of sleep disorders in SCI/ D is critical for the development of new effective therapies. This review provides evidence for best practices, highlights new discoveries for the diagnosis and management of sleep disorders in SCI/D, and discusses challenges and future directions.
Introduction
Spinal cord injury/disorder (SCI/D) is the second leading cause for paralysis in the USA after stroke [1] . It is estimated that 1,275,000 persons in the USA are living with SCI/D [2] with approximately 12,400 new SCI/Ds a year [3] . Most SCI/ D occurs during the second or third decade of life, leading to a major impact on young individuals in the community. The life expectancy for those who survive after the first year approaches the normal population, and as a result, chronic illnesses impose significant health consequences and increased cost for many years. SCI/D alone costs roughly $40.5 billion annually (a study sponsored by the Christopher and Dana Reeve Foundation-date accessed is on 8/8/2016) [4] , and managing comorbid disorders, including sleep disorders, in this patient population can be challenging.
Overview of Sleep Disturbances in Individuals with Spinal Cord Injury
The majority of spinal cord injury (SCI) individuals report poor sleep quality and increased rates of sleep disturbances compared to the general population, including patients with other neurological disorders that share similar morbidity [5] . The mechanisms underlying sleep disturbances in SCI are multi-factorial and may include pain, bladder dysfunction, depression, circadian dysfunction, and medication use. Furthermore, sleep disturbances may exacerbate chronic complaints such as depressed mood and impaired cognitive performance. Therefore, the relationship between sleep disturbance and co-morbid conditions is bidirectional and requires a comprehensive approach that addresses sleep and chronic conditions simultaneously.
Insomnia is a common sleep disorder, occurring in 10% of healthy adults has not been well-studied among SCI/D patients [6] . One study found that 22% of individuals with multiple sclerosis met diagnostic criteria for insomnia disorder [7] ; however, rates in patients with spinal cord injuries are not known. Some studies suggest that insomnia may contribute to depression and poor quality of life [8] . Also, studies show that insomnia is common among other patient populations after injury (e.g., traumatic brain injury) [9] , and there is some evidence that these patients can benefit from adapted versions of standard treatment of insomnia [10] .
Abnormal leg movements, including periodic leg movements (PLM) and restless legs syndrome (RLS), contribute to disrupted sleep. The prevalence in the general population is estimated to be 4 and 5.5% for PLM and RLS, respectively [11] . Emerging data suggest that the prevalence of PLMs is higher in patients with SCI relative to the general population [12, 13] . In a recent study, Peters et al. [14] found that more than 40% of patients with tetraplegia had PLMs, which were evident during REM and NREM sleep as well as wakefulness. Interestingly, one study reported that physical activity improved both PLM and RLS severity in a group of volunteers with low-thoracic complete SCI (T7-11), which was thought to be due to increased release of endorphins after physical activity [12] . Overall, it appears that PLMs are common in patients with SCI, independent of obstructive sleep apnea (OSA), and may contribute to poor nocturnal sleep.
The mechanisms of sleep disturbances may also vary by the level of injury. Specifically, nocturnal melatonin secretion is diminished, or absent, in patients with complete cervical SCI [15] , owing to the interruption of sympathetic innervation to the pineal gland. This may therefore suggest circadian disruption as a contributory factor to poor overall sleep.
However, the lack of a therapeutic benefit following the administration of melatonin or melatonin receptor agonists in patients with tetraplegia underscores the multi-factorial etiology of sleep disturbances in this population and the need to address the full continuum of factors that may disturb sleep [16] .
Sleep-disordered breathing (SDB) is a common cause of sleep disturbances in individuals living with SCI/D. The prevalence of SDB is two-to fourfold higher than the general population [17, 18•, 19••, 20] , likely making it the most common sleep disorder in this patient population. There is evidence that SDB develops within a few months following the injury [17] , indicating that SCI/D may be an independent risk factor for the development of SDB. However, SDB remains woefully under-recognized and under-diagnosed in patients with SCI/D despite the recognized adverse consequences of SDB and the high frequency of sleep disturbances in SCI/D patients [21] . One reason that SDB is critically important in these patients is that cardiopulmonary complications are major causes of morbidity and mortality in SCI/D patients because of decreased lung volume, ineffective cough, mucus retention, and atelectasis [22, 23] . In fact, cardiovascular conditions have superseded respiratory causes of death in cervical SCI/D patients and have become the most common cause for mortality in this disabled population [24] . On the basis of the extensive literature linking untreated SDB to cardiovascular mortality, SDB may represent a treatable risk factor among SCI/D patients. The following discussion will focus on the etiology, manifestations, and consequences of SDB in this population.
Epidemiology of SDB in Patients with SCI/D
The prevalence of SDB in sub-acute and chronic SCI population depends on the threshold of diagnosis based on an index called apnea-hypopnea index (AHI). This index consists of two types of events: apneas and hypopneas. Apneas are complete cessation of airflow and could be further classified into obstructive apneas caused by complete recurrent upper airway obstruction, despite persistent respiratory (can't breathe), and central apneas caused by periodic cessation of respiratory effort (won't breathe). These two types of apnea often co-exist in individual patients. The other types of respiratory events are hypopneas, which represent decrease flow and hence decreased alveolar ventilation. While hypopneas can also be classified as obstructive or central, the distinction is often difficult on a clinical polysomnogram (PSG). The apnea/hypopnea index (AHI) is a composite index including the total number of apnea and hypopneas per hour of sleep. Importantly, patients with SCI/D often experience a combination of these respiratory events.
Several epidemiological studies have found a high prevalence of SDB in sub-acute and chronic SCI patients (ranging between 27 and 82%) [17, 18•, 19••, 20, 25, 26] . The heterogeneity in the estimated prevalence is related to multiple factors, including testing patents with different levels of SCI, using different modes of testing from nocturnal oximetry, portable monitoring, or in-laboratory polysomnography, and using different thresholds of apnea-hypopnea index and different definition of respiratory events (especially hypopnea events). Use of limited recordings may prevent recognition of respiratory events that can only be identified using PSG.
The type of SDB and prevalence may depend also on the level of injury. For example, patients with cervical SCI have higher prevalence of SDB than thoracic SCI [18•] . In a study by Berlowitz et al. (2005) [17] , it was found that the prevalence of SDB in an Australian cohort of cervical SCI was 62% in the four weeks immediately post-injury and remained 60% after one-year follow-up. Respiratory complications are the major causes of morbidity and mortality in patients with SCI particularly at the cervical level [27] . Our group has been studying SDB among SCI patients, and we have found that SDB, defined by the AHI ⩾ 5 events per hour, was present in 77% of chronic SCI patients, with rates higher among those with cervical compared those with thoracic injuries (93 vs 55%, respectively, P < 0.05) [18•] . We also found that one in four cervical SCI patients had a CheyneStokes respiration pattern during their overnight in-laboratory sleep study.
Mechanisms of SDB in SCI-the Perfect Storm
The complex mechanisms responsible for increased prevalence of SDB in patients with SCI include anatomic and neuromuscular factors, as well as factors related to the injury per se, such as the level and time since the injury. The development of SDB can be directly attributed to SCI, as it can occur as early as 2 weeks following acute cervical spinal injury. Several factors may play an important role in the pathogenesis of SDB in SCI including level and completeness of injury [28, 29] , concomitant neuromuscular weakness [27] , large neck size [17] , increased upper airway collapsibility [30] , exposure to chronic intermittent hypoxia [31, 32••] , presence of sleep-related hypoventilation [28] , and the use of medications that affect respiration such muscle relaxants, sedatives, and opioids [19••] .
To understand the etiology of SDB in patients with SCI, it is important to recognize that sleep is a physiologic challenge, rather than relief, for the respiratory system. Several physiologic changes increase the propensity to develop apnea or hypopneas during sleep, and this propensity may be higher in SCI/D patients than in adults without SCI/D.
First, reduced activity of upper airway dilators is associated with upper airway narrowing and increased upper airway resistance. Snoring occurs when upper airway resistance increases significantly, leading to Bfluttering^of the soft palate due to turbulent flow. In extreme cases of upper airway narrowing, complete closure may occur, leading to obstructive sleep apnea. Second, the sleep state (specifically non-rapid eye movement or NREM sleep) removes the wakefulness Bdrive to breathe,^rendering respiration critically dependent on PaCO 2 (arterial CO 2 ). Specifically, NREM sleep unmasks the hypocapnic apneic threshold; thus, central apnea occurs if arterial PaCO 2 falls a highly sensitive Bapneic threshold.^Overall, the sleep-related upper airway narrowing and unmasking of the apneic threshold is critical sleep effects that predisposes to the development of obstructive and central apnea, respectively.
The physiologic effects of sleep may be well tolerated in healthy individuals; however, patients with SCI-especially cervical SCI-suffer from the full continuum of derangements that impair the ability of the ventilatory system to compensate for physiologic challenges of sleep, including neuromuscular weakness, small lung volume, abnormal chest wall mechanics, frequent use of CNS suppressants, and an unopposed parasympathetic system promoting airway narrowing. This may explain the very high prevalence of SDB in this population.
Sleep-related hypoventilation is a universal physiologic phenomenon but is more pronounced in patients with cervical SCI [28] , given diminished ventilatory motor neural output to respiratory muscles, the presence of restrictive ventilatory defect, loss of sympathetic innervations, and impaired respiratory mechanics. The aforementioned factors, combined with impaired load compensation, and the use of analgesics/ hypnotics result in worsening alveolar hypoventilation and ventilatory decompensation. Thus, it is not surprising that SDB is common in sub-acute and chronic SCI patients.
Role of Ventilatory Control
Ventilatory control during sleep operates as a negative feedback closed-loop cycle, often described in using the engineering concept of Bloop gain^as a framework for breathing instability [33] . The propensity to central apnea during NREM sleep is determined by an interaction between the response of the brain and chemoreceptors to changing P ET CO 2 , representing the controller, and the effectiveness of the lung/respiratory system in lowering P ET CO 2 in response to hyperventilation (the plant).
The occurrence of central apnea may initiate several processes that promote further instability including inertia of the ventilatory control system, hypoxia, and transient arousal, with ensuing ventilatory overshoot, hypocapnia, and recurrent central apnea. A less-recognized phenomenon is that central apnea may also influence the development of OSA. There is evidence that patients with unfavorable upper airway anatomy are dependent on ventilatory motor output to preserve upper airway patency, with pharyngeal narrowing and/or occlusion occurring during central apnea [34] .
We recently found that more than 90% cervical SCI patients demonstrated SDB, with the majority demonstrating central SDB, not explained by daytime hypoventilation, cardiac dysfunction, or use of narcotics [18•] . The SDB events in cervical SCI patients were predominantly central while events in the thoracic SCI group were obstructive [18• ]. This unique observation may have significant implications regarding the mechanism of SDB in patients with SCI. Recent data in animal SCI models showed that cervical SCI predisposes to alterations in ventilatory motor output suggesting an important role for breathing instability in the development of SDB in SCI patients [35] . To determine the susceptibility to central apnea in cervical and thoracic SCI compared to able-bodied controls, we induced hyperventilation using non-invasive ventilation in chronic SCI patients and measured the CO 2 reserve (a marker of susceptibility to central apnea), plant grain, and ventilation during sleep [36] . We found that the CO 2 reserve was narrower in cervical SCI patients compared to that in thoracic SCI patients and able-bodied comparison subjects, and plant gain was increased in cervical SCI compared to the thoracic and able-bodied subjects. Specifically, we have found that chronic cervical SCI patients demonstrate a central periodic breathing pattern with spontaneously occurring central apnea, that is, a very close proximity between eupneic P ET CO 2 (end-tidal CO 2 ) and the hypocapnic apneic threshold. Despite this, many cervical SCI patients in the supine position can maintain minute ventilation with a normal respiratory rate and tidal volume [18•] . In contrast, these patients will often have significantly decreased tidal volume when they transition from wake to sleep [28] .
Upper Airway Collapsibility
Increased upper airway (UA) collapsibility plays an important role in the pathogenesis of SDB in able-bodied individuals [37, 38] . Available evidence suggests that individuals living with thoracic or lower SCI are at increased risk of SDB, mostly obstructive sleep apnea, due to higher prevalence of the same risk factors of OSA in the general population, such as obesity and male gender [17] . In contrast, the etiology of SDB in patients with cervical SCI is particularly complex, as these individuals have risk factors for UA obstruction as well as increased propensity to recurrent central apnea during sleep. We have recently demonstrated that the SCI individuals exhibit elevated passive critical closing pressure (Pcrit), indicative of increased upper airway collapsibility [30] .
However, upper airway resistance was similar between the three groups. However, similar increase in the inspiratory duty cycle was noted in chronic SCI and was independent of the level of injury. Furthermore, it was reported recently that nasal resistance is elevated in people with cervical SCI which is believed to be due to unopposed parasympathetic activity [39] . But the mechanistic contribution of increased nasal resistance to UA collapsibility is unclear.
Neuromuscular Output
While high cervical SCI leads to severe impairment of the respiratory muscles including the diaphragm, mid and low cervical lesions spare most respiratory muscles [40] . Specifically, decreased ventilatory neuromuscular output caused by intercostal muscle paralysis plays an important role in the development of sleep apnea shortly post-injury to the cervical spine, while increased chemoreflex sensitivity and control of breathing mechanisms rostral to the injury level may contribute to the residual neuromuscular impairment and reduced lung volume in chronic tetraplegia when ventilation is more dependent on O 2 and CO 2 levels [41] . As illustrated in Fig. 1 , pronounced sleep-related hypoventilation occurs in cervical SCI patients [28] , secondary to loss of intercostal muscle activity. Hypoventilation, combined with enhanced chemoreflex sensitivity, may contribute to respiratory instability by increasing plant gain and controller gain, respectively.
Clinical Implications of SDB in SCI Patients
There is a strong relationship between SDB and cardiovascular disease in SCI. One in five of persons with SCI has hypertension or cardiac disease [21] . Furthermore, cardiac medication use has been found to be higher in tetraplegic patients who have SDB which may implicate a link between SDB and cardiovascular morbidities in SCI patients [25] . In a retrospective study of SCI patients, those with cervical injuries were found to have more reversed dipping (i.e., higher blood pressure at night rather than during the day) and nocturnal hypertension compared to those with thoracic injuries [42] . The strong relationship between untreated SDB and nocturnal hypertension had been repeatedly confirmed in able-bodied individuals with SDB [1, 43] . Ambulatory BP monitoring allows accurate assessment of circadian BP changes, which can identify a blunted nocturnal decline in BP and indicate the possible secondary cause of hypertension, such as sleep apnea. Specifically, the non-dipping BP phenomenon measured by ambulatory BP monitoring was found in to be predominant in patients with acute cervical SCI [44] and in untreated able-bodied patients with SDB and was associated with poor outcome. Importantly, this phenomenon can be improved with CPAP treatment [45] . However, longterm outcome data on the effect of untreated SDB in individuals with SCI are lacking, in part due to challenges in the use of positive airway pressure (PAP) for patients with SCI.
Challenges in the Diagnosis and Treatment of SDB Among SCI Patients
We recently reviewed the medical records of 168 veterans with SCI [21] and found that only 37 patients (22%) had been evaluated for SDB of whom 34 (20%) had SDB diagnosis confirmed by an overnight sleep study. In other words, a clinical evaluation for possible sleep disorders was conducted in only one out of five patients, despite the overwhelming prevalence of sleep disorders in this population. One reason that SDB remains underdiagnosed in patients with SCI, especially cervical SCI, partly due to limited access to in-lab testing [46] . Many sleep labs are simply not equipped to handle patients with limited mobility or those who cannot independently transfer in and out of bed.
However, the challenges in diagnosing SDB are also coupled with limited use of standard PAP therapy in this patient group. In the same study, we also found that of the 34 patients with diagnosed SDB, only 6 patients (18%) were using PAP therapy. The treatment of choice for SDB is PAP therapy. Adherence to PAP therapy, however, remains a challenge despite education, follow-up, and support [47] . Particularly, since patients with SCI may be less adherent to PAP therapy than able-bodied individuals, alternative therapies beyond PAP are needed. Some factors that lead to discontinuation of therapy are related to weakness and mobility impairment to the upper extremities, mask claustrophobia, increased awakenings, nasal congestion, lack of education, and inconvenience. Many of these can be mitigated through avoidance of large full-face masks and use nasal interface and PAP education.
Challenges in diagnosing and treating SDB may need to be addressed by educating both patients and providers. This is particularly important given the increase in prevelance of SDB in patients with SCI/D and the potential impact on quality of life and incidence of comobid illnesses such as heart disease, stroke, hypertension and poor cognition. It is also important to address PAP adherence specifically in SCI/D patients and to develop and test novel treatments, other than PAP, for patients who are unable to tolerate this standard approach.
Conclusion
Sleep disturbances, particularly sleep-disordered breathing, are common among individuals with SCI across different demographics and levels of spinal cord injuries. The mechanism(s) for increased prevalence of SDB after surviving SCI are not clear yet but evidence point toward complex pathways that include upper airway collapsibility, ventilatory instability, reduced lung volume, sleep-related hypoventilation, and neuromuscular weakness. Therefore, conventional therapies may not be fully accepted by these disabled patients with many chronic issues, and individualized care is greatly needed. Further studies are required in human and pre-clinical models to elucidate the exact etiology of disease and identify therapeutic targets that are effective in improving symptoms and preventing resulting comorbidities. 
